PTEN and neoplasm: Amplification, or gain of function mutations in PI3K, AKT, or loss of function PTEN mutations, serve to activate mTOR thus inhibiting autophagy, and have, therefore, been defined as underlying mechanisms for oncogenicity, suggesting a potential importance of suppressing autophagy during tumor initiation112,115.